Notes: Rotate injection sites with each administration
Concentration = 10 mg 3 mL = 3.33 mg/mL (3,333 mcg/mL)
Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway
Copay savings cards: Even without full coverage, these cards can significantly lower your monthly cost
However, a 2025 meta-analysis published in the Journal of the American Heart Association found that people who had been taking GLP-1 medications for 78 weeks or longer (roughly a year and a half) had a significantly higher risk of developing a DVT compared to non-users
In addition to injectable preparations such as insulin and insulin analogs, glucagon-like peptide 1and oral hypoglycemic drugs, such as peptidyl peptidase-4 (DPP-4) inhibitors and sodium-glucose co-transporter 2 (SGLT2) inhibitor, are commonly used to treat diabetes (Green et al., 2018), and combination therapy